A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery

Journal of the Royal College of Surgeons of Edinburgh

Volumn 43, Issue 5, 1998, Pages 344-346

  Zohdy, G A ^a   Rogers, Z A ^a   Lukaris, A ^a   Sells, M ^a   Roberts Harry, T J ^a  

^a WEST WALES GENERAL HOSPITAL   (United Kingdom)

Author keywords

Acetazolamide; Carbonic anhydrase inhibitors; Dorzolamide; Extracapsular cataract extraction (ECCE); Intraocular pressure (IOP); Phacoemulsification

Indexed keywords

ACETAZOLAMIDE; ACETYLCHOLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBACHOL; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; HYALURONIC ACID; PILOCARPINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; EYE SURGERY; FEMALE; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; LENS IMPLANT; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; TOPICAL DRUG ADMINISTRATION;

ACETAZOLAMIDE; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; SULFONAMIDES; THIOPHENES;

EID: 0031710844     PISSN: 00358835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hayreh SS. Anterior ischaemic optic neuropathy. IV. Occurrence after cataract extraction. Arch Ophthalmology 1980; 98: 1410-16.
2. Gross JG, Meyer DR, Robin AL, Filar AA, Kelly JS. Increased IOP in the immediate post-operative period after extracapsular cataract extraction. Am J Ophthalmology 1988; 105: 466-9.
3. Pape LG, Balazs EA. The use of sodium hyaluronate (Healon®) in human anterior segment surgery. Ophthalmology 1980; 87: 699-705.
4. Stegmann R, Miller D. Extracapsular cataract extraction with hayluronate sodium. Ann Ophthalmology 1982; 14: 813-5.
5. Stamper R L, Diloreto D, Schacknow P. Effect of intraocular aspiration of sodium hayluronate on post-operative IOP. Ophthalmic Surg 1990; 21: 486-91.
6. Olivius E, Thorburn W. IOP after cataract surgery with Healon®. Am Intra-Ocular Implant Soc J 1985; 11: 480-2.
7. Storr-Paulsen A. Analysis of the short-term effect of two viscoelastic agents on the IOP after extracapsular cataract extraction: sodium hyaluronate 1% versus hydroxypropyl methylcellulose 2%. Acta Ophthalmologica 1993; 71 (2): 173-6.
8. Holland R H, Drance SM, Schulzer M. The effect of intracameral carbachol on IOP after cataract extraction. Am J Ophthalmology 1987; 104: 225-8.
9. Ruiz RS, Rhem MN, Prager TC. Effects of carbacol and acetylcholine on IOP after cataract extraction. Am J Ophthalmology 1989; 107: 7-10.
10. Ruiz RS, Wilson CA, Musgrove KH, Prager TC. Management of increased IOP after cataract extraction. Am J Ophthalmology 1987; 103: 487-91.
11. Fry LL. Comparison of the post-operative IOP with Betagan, Betoptic, Timoptic, Iopidine, Diamox, Pilocarpine gel and Miostat. J Cataract Refract Surg 1992; 18: 14-19.
12. Siegel MJ, Camras CB, Lustgarten JS, Podos SM. Effect of flurbiprofen on the reduction of IOP after administration of 1% apraclonidine in patients with glaucoma. Arch Ophthalmology 1992; 110: 589-99.
13. Rich WJCC. Further studies on early post-operative ocular hypertension following cataract extraction. Trans Ophthalmol Soc UK 1969; 89: 639-45.
14. Packer AJ, Fraioli AJ, Epstein D L. The effect of timolol and acetazolamide on transient IOP elevation following cataract extraction with alpha chymotrypsin. Ophthalmology 1981; 88: 239-43.
15. Lewen R, Insler MS. The effect of prophylactic acetazolamide on the IOP rise associated with Healon-aided intraocular lens surgery. Ann Ophthalmol 1985; 17: 315-18.
16. McKinzie JW, Boggs MB Jr. Comparison of post-operative IOPs after use of Miochol and Miostat. J Cataract Refract Surg 1989; 15: 185-90.
17. Marren T H, Bra-Ilan A, Conroy CW, Brechue WF. Chemical and pharmacological properties MK-927, a sulphonamide carbonic anhydrase inhibitor that lowers IOP by the topical route. Exp Eye Res 1990; 50: 27-36.
18. Wang R-F, Serie JB, Podos SM, Sugrue MF. The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671 152 in glaucomatous monkeys. Arch Ophthalmol 1990; 108: 511-13.
19. Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS. A comparison of L-671 152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors in experimental animals. Curr Eye Res 1990; 9: 607-15.
20. Baldwin JJ, Ponticello GS, Anderson PS, Christy ME, Murcko MA, Randall WC, et al. Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma. J Med Chem 1989; 32: 2510-13.
21. Lippa EA, Carlson LE, Ehinger B, Eriksson LO, Holmin C, Nilsson SE et al. Dose response and duration of action of dorzolamide: a topical carbonic anhydrase inhibitor. Arch Ophthalmology 1992; 110: 495-99.
22. th Singapore 1990.